Frequencies of <i>IFN-L4</i> and <i>IFN-L3</i> genotypes (ss469415590, rs12979860, rs8099917) in HCV genotype 1, 2, 3, and 4 infected patients and different treatment outcomes.
- Simone Susser (48294)
- Eva Herrmann (139197)
- Christian Lange (70151)
- Nabila Hamdi (660095)
- Tobias Müller (163591)
- Thomas Berg (186372)
- Dany Perner (660096)
- Stefan Zeuzem (22856)
- Christoph Sarrazin (48298)
Publication date
November 2014
DOIAbstract
<p>GT1(d) – HCV genotype 1 infected patients receiving dual-therapy (PEG-INF + Ribavirin); GT1(t) – HCV genotype 1 infected patients receiving triple-therapy (TPR + PEG-INF + Ribavirin); <sup>1</sup>p-value from χ2 test; <sup>2</sup>p-value from Fisher-Freeman-Halton’s exact test.</p><p>Frequencies of <i>IFN-L4</i> and <i>IFN-L3</i> genotypes (ss469415590, rs12979860, rs8099917) in HCV genotype 1, 2, 3, and 4 infected patients and different treatment outcomes.</p
Add to ORKG